AVE 20.0% 0.3¢ avecho biotechnology limited

Ann: Metabolic Syndrome Trial Results , page-102

  1. 10,009 Posts.
    Playez, If any interested shareholders can attend I will turn up. However it lends weight to my statement regarding announcements. If they communicated the information correctly we wouldn.t need a special delegation. I posted earlier regarding the response from the ACL CEO to a shareholder. More quality info in that one letter than we have had in the last 5 years.

    We wouldn't have all this debate if the standard of communication was where it should be. That's the guts of it. We wouild have sufficient information to make a solid decision IN or OUT. That information should also include negatives and potential pitfalls that lay ahead.

    PoS.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(20.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $2.635K 1.045M

Buyers (Bids)

No. Vol. Price($)
57 93538418 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 60456317 21
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.